Article
Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease.
Journal of the American Society of Nephrology : JASN - 1 Apr 2017
Challis Rachel C, Ring Troels, Xu Yaobo, Wong Edwin K S, Flossmann Oliver, Roberts Ian S D, Ahmed Saeed, Wetherall Michael, Salkus Giedrius, Brocklebank Vicky, Fester Julian, Strain Lisa, Wilson Valerie, Wood Katrina M, Marchbank Kevin J, Santibanez-Koref Mauro, Goodship Timothy H J, Kavanagh David
Abstract excerpt
The demonstration of impaired C regulation in the thrombotic microangiopathy (TMA) atypical hemolytic uremic syndrome (aHUS) resulted in the successful introduction of the C inhibitor eculizumab into clinical practice. C abnormalities account for approximately 50% of aHUS cases; however, mutations in the non-C gene diacylglycerol kinase-ε have been described recently in individuals not responsive to eculizumab....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
